Breaking News

Walmart continues adding to its healthcare offerings

Not rendering correctly? View this email as a web page here.

Scipher Medicine's blood test shows the benefits of precision medicine in rheumatoid arthritis

By Arundhati Parmar Tuesday, February 1, 2022 8:00 AM

The Study to Accelerate Information of Molecular Signatures (AIMS) found RA patients whose treatment was guided by the PrismRA blood test had three times better clinical responses compared to patients that didn't.

Read more »

Digital collaboration here to stay beyond pandemic for Merck, Pfizer, others

By Emma Bardin Monday, January 31, 2022 11:58 PM

A recent survey pulled medical affairs thought leaders and found that a majority see asynchronous virtual options in conjunction with in-person as the preferred path moving forward to conduct advisory board meetings, steering meetings, and other such communications, versus just in-person.

Read more »

Pfizer bows out of developing cardio drug, returns rights to Ionis Pharmaceuticals

By Arundhati Parmar Monday, January 31, 2022 7:34 PM

Sometimes even a clinical trial where the endpoints have been met may not give the […]

Read more »

Two firms team up to facilitate at-home screenings to prevent blindness

By Michael Schroeder Monday, January 31, 2022 6:40 PM

MedArrive providers will use Spect's artificial intelligence-enabled telemedicine platform to screen patients at home for eye diseases such as diabetic retinopathy, glaucoma and age-related macular degeneration.

Read more »

Who is speaking at HLTH and CHIME's newest conference ViVE? [Sponsored]

By Stephanie Baum Monday, January 31, 2022 4:33 PM

The ViVE conference, scheduled for March 6-9 in Miami Beach, has announced a roster of speakers that will share valuable insights on healthcare garnered from leadership roles across big tech, retail health, health systems, payers and more.

Read more »

Biotech firm leveraging AI to analyze protein interactions launches with $40M Series A funding

By Emma Bardin Monday, January 31, 2022 8:00 AM

Gandeeva Therapeutics to use $40M from series A funding to develop their AI-enabled cryo-EM platform for end-to-end drug discovery, shaving down cost and time to produce drug candidates.

Read more »

   

No comments